Dysregulation and detection methods of EGFR in oral cancer. A narrative review.

Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein, with an intracellular domain and tyrosine kinase function (TK) involved in cell proliferation. Dysfunctions in EGFR signaling pathways have been associated with oral malignant tumors such as oral squamous cell carcinoma (OSCC)....

Full description

Bibliographic Details
Main Authors: Carolina Somarriva, Alejandra Fernández, Jorge Candia, Javier Campos, Daniela Albers, Jorge Briceño
Format: Article
Language:English
Published: Universidad de Concepción. 2016-11-01
Series:Journal of Oral Research
Subjects:
Online Access:http://www.joralres.com/index.php/JOR/article/view/270/260
_version_ 1811312477137272832
author Carolina Somarriva
Alejandra Fernández
Jorge Candia
Javier Campos
Daniela Albers
Jorge Briceño
author_facet Carolina Somarriva
Alejandra Fernández
Jorge Candia
Javier Campos
Daniela Albers
Jorge Briceño
author_sort Carolina Somarriva
collection DOAJ
description Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein, with an intracellular domain and tyrosine kinase function (TK) involved in cell proliferation. Dysfunctions in EGFR signaling pathways have been associated with oral malignant tumors such as oral squamous cell carcinoma (OSCC). Dysfunctions of EGFR may result from: increased EGF ligand; EGFR overexpression and copy number gain of the EGFR gene (EGFR CNG); EGFR mutations; failure in the downregulation of EGFR; and EGFR crosstalk. Of these alterations, overexpression of EGFR is by far the most studied dysfunction in OSCC. Clinicians should identify possible alterations of EGFR in the oral mucosa of patients, as EGFR can act as a biomarker for the diagnosis and prognosis of OSCC. Currently, there are several methods and techniques for detecting EGFR. Immunohistochemistry (IHC), fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR), are used to identify overexpression of EGFR, EGFR CNG and EGFR mutations, respectively. Detection of EGFR as a biomarker is key to identify any oral malignant transformation. Consequently, it becomes imperative to implement a non-invasive and inexpensive method of early diagnosis for OSCC in clinical practice.
first_indexed 2024-04-13T10:38:00Z
format Article
id doaj.art-495eb1f90ec94c23b366d5129924b7a2
institution Directory Open Access Journal
issn 0719-2460
0719-2479
language English
last_indexed 2024-04-13T10:38:00Z
publishDate 2016-11-01
publisher Universidad de Concepción.
record_format Article
series Journal of Oral Research
spelling doaj.art-495eb1f90ec94c23b366d5129924b7a22022-12-22T02:50:00ZengUniversidad de Concepción.Journal of Oral Research0719-24600719-24792016-11-015728529210.17126/joralres.2016.057Dysregulation and detection methods of EGFR in oral cancer. A narrative review.Carolina Somarriva0Alejandra Fernández1Jorge Candia2Javier Campos3Daniela Albers4Jorge Briceño5Facultad de Odontología. Universidad Andres Bello. Chile.Facultad de Odontología. Universidad Andres Bello. Chile. Centro de Investigación Biomédica. Universidad de Los Andes, Chile.Facultad de Odontología. Universidad Andres Bello. Chile.Centro de Investigación Biomédica. Universidad de Los Andes, Chile.Centro de Investigación Biomédica. Universidad de Los Andes, Chile. Facultad de Odontología. Universidad Mayor, Chile.Facultad de Odontología. Universidad Andres Bello. Chile.Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein, with an intracellular domain and tyrosine kinase function (TK) involved in cell proliferation. Dysfunctions in EGFR signaling pathways have been associated with oral malignant tumors such as oral squamous cell carcinoma (OSCC). Dysfunctions of EGFR may result from: increased EGF ligand; EGFR overexpression and copy number gain of the EGFR gene (EGFR CNG); EGFR mutations; failure in the downregulation of EGFR; and EGFR crosstalk. Of these alterations, overexpression of EGFR is by far the most studied dysfunction in OSCC. Clinicians should identify possible alterations of EGFR in the oral mucosa of patients, as EGFR can act as a biomarker for the diagnosis and prognosis of OSCC. Currently, there are several methods and techniques for detecting EGFR. Immunohistochemistry (IHC), fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR), are used to identify overexpression of EGFR, EGFR CNG and EGFR mutations, respectively. Detection of EGFR as a biomarker is key to identify any oral malignant transformation. Consequently, it becomes imperative to implement a non-invasive and inexpensive method of early diagnosis for OSCC in clinical practice.http://www.joralres.com/index.php/JOR/article/view/270/260Epidermal Growth Factor ReceptorMouth NeoplasmMutation.
spellingShingle Carolina Somarriva
Alejandra Fernández
Jorge Candia
Javier Campos
Daniela Albers
Jorge Briceño
Dysregulation and detection methods of EGFR in oral cancer. A narrative review.
Journal of Oral Research
Epidermal Growth Factor Receptor
Mouth Neoplasm
Mutation.
title Dysregulation and detection methods of EGFR in oral cancer. A narrative review.
title_full Dysregulation and detection methods of EGFR in oral cancer. A narrative review.
title_fullStr Dysregulation and detection methods of EGFR in oral cancer. A narrative review.
title_full_unstemmed Dysregulation and detection methods of EGFR in oral cancer. A narrative review.
title_short Dysregulation and detection methods of EGFR in oral cancer. A narrative review.
title_sort dysregulation and detection methods of egfr in oral cancer a narrative review
topic Epidermal Growth Factor Receptor
Mouth Neoplasm
Mutation.
url http://www.joralres.com/index.php/JOR/article/view/270/260
work_keys_str_mv AT carolinasomarriva dysregulationanddetectionmethodsofegfrinoralcanceranarrativereview
AT alejandrafernandez dysregulationanddetectionmethodsofegfrinoralcanceranarrativereview
AT jorgecandia dysregulationanddetectionmethodsofegfrinoralcanceranarrativereview
AT javiercampos dysregulationanddetectionmethodsofegfrinoralcanceranarrativereview
AT danielaalbers dysregulationanddetectionmethodsofegfrinoralcanceranarrativereview
AT jorgebriceno dysregulationanddetectionmethodsofegfrinoralcanceranarrativereview